Veraxa Biotech AG Ordinary Shares (VRXA) is a publicly traded the market company. As of July 28, 2026, VRXA trades at $2.08 with a market cap of $254.53M and a P/E ratio of 0.00. VRXA moved +3.23% today. Year to date, VRXA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $1.70 to $27.36. Rallies surfaces VRXA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest VRXA news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $2.08 |
| Market Cap | $254.53M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.36 |
| 52-Week Low | $1.70 |
| Volume | 4.61K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
VRXA analyst coverage data. Average price target: $0.00.